Difficulty: Medium
Average Score: 67%
Practice
A nurse is preparing to administer a drug. Upon reading the medication guide, the nurse notes that the drug has been linked to symptoms of Parkinson disease in some patients. What will the nurse do?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Observe the patient closely for such symptoms and prepare to treat them if needed. This is the most appropriate action for the nurse to take when faced with a medication that has been linked to symptoms of Parkinson's disease in some patients.
Observing the patient closely allows the nurse to monitor for any emerging symptoms and intervene promptly if needed. This proactive approach is crucial in ensuring patient safety and well-being. By being vigilant and prepared to treat potential symptoms, the nurse can mitigate any adverse effects of the medication.
Option A is incorrect because asking the patient to report teratogenic effects is not relevant in this context as the issue at hand pertains to symptoms of Parkinson's disease, not teratogenic effects. Option C is incorrect as evaluating genetic predisposition is not a standard practice in this situation unless there is specific evidence to suggest a genetic link. Option D is incorrect as simply warning the patient without a plan for monitoring and intervention is not sufficient in ensuring patient safety.
In an educational context, this question highlights the importance of pharmacovigilance and the nurse's role in monitoring for adverse effects of medications. It emphasizes the need for proactive assessment and intervention to ensure patient safety and optimal outcomes. Nurses must be knowledgeable about potential side effects of medications and be prepared to take appropriate actions when administering them.
Observing the patient closely allows the nurse to monitor for any emerging symptoms and intervene promptly if needed. This proactive approach is crucial in ensuring patient safety and well-being. By being vigilant and prepared to treat potential symptoms, the nurse can mitigate any adverse effects of the medication.
Option A is incorrect because asking the patient to report teratogenic effects is not relevant in this context as the issue at hand pertains to symptoms of Parkinson's disease, not teratogenic effects. Option C is incorrect as evaluating genetic predisposition is not a standard practice in this situation unless there is specific evidence to suggest a genetic link. Option D is incorrect as simply warning the patient without a plan for monitoring and intervention is not sufficient in ensuring patient safety.
In an educational context, this question highlights the importance of pharmacovigilance and the nurse's role in monitoring for adverse effects of medications. It emphasizes the need for proactive assessment and intervention to ensure patient safety and optimal outcomes. Nurses must be knowledgeable about potential side effects of medications and be prepared to take appropriate actions when administering them.